Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain

Starting soon · Early Phase 1

Conditions studied: Refractory Cancer Pain, Cancer Pain

In brief

This trial aims to address refractory cancer pain (RCP). It will explore the synergistic efficacy and safety of hydromorphone hydrochloride sustained-release tablets (HHST) combined with electroacupuncture (EA) and ear acupoint pressing beans (EAPB) for RCP. Key outcomes will include dynamic changes in Numerical Rating Scale (NRS) scores, proportions of patients with effective analgesia (≥30% NRS reduction from baseline) and marked remission (≥50% NRS reduction from baseline), daily HHST dosage, breakthrough pain (BP) frequency, and drug-related adverse events (AEs) graded by CTCAE 5.0.

Key facts

Study ID

NCT07489625

Run by

Qinghai Red Cross Hospital

People needed

30

Starts

2026-03-07

Expected to finish

2028-12-31

Last updated by the study team

2026-03-24

Who can join

Age: 19 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who meet the diagnostic criteria for cancer ;
• Diagnosis of refractory cancer pain;
• Aged 19 or 80 years;
• Expected survival period ≥3 months;
• Karnofsky Performance Status (KPS) score ≥30 and Quality of Life (QOL) score ≥20;
• No history of allergy to opioid analgesics;
• No intellectual or psychiatric disorders; normal comprehension ability,capable of cooperating with pain assessments and questionnaire completion;
• Provision of signed written informed consent.

You may not qualify if…

• Patients with pain clearly unrelated to the tumor itself;
• Patients with pain relief after standardized pharmacological treatment;
• Patients aged under 19 years or over 80 years;
• Patients with an expected survival of less than 3 months;
• Patients with a Karnofsky Performance Status (KPS) score < 30 or Quality of Life (QOL) score < 20;
• Pregnant or lactating women;
• Patients with intellectual disability, mental or consciousness disturbance, who are unable to assess pain accurately or complete questionnaire surveys;
• Patients with needle phobia or extreme resistance to acupuncture treatment;
• Patients with hypersensitivity to Semen Vaccariae (Wang Bu Liu Xing).

Where it is running

• Qinghai Red Cross Hospital — Xining, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.